April 16, 2021

Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Co

Track this case

Case Number:



Appellate - 9th Circuit

Nature of Suit:

4110 Insurance

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. January 11, 2022

    9th Circ. Skeptical Of Coverage For Co.'s Opioid Probe Costs

    A Ninth Circuit panel seemed poised to secure U.S. Specialty Insurance Co.'s win in a coverage dispute with an opioid drugmaker seeking to recover $2.4 million it spent responding to government subpoenas, with one judge saying that the language of a key exclusion was broad but unambiguous.

2 other articles on this case. View all »


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!